Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -695 | -2,947 | -2,221 | -1,529 | -1,858 |
| Accounts receivable | N/A | N/A | N/A | -800 | N/A |
| Other Working Capital | 197 | 300 | 682 | -228 | 447 |
| Other Operating Activity | 60 | 814 | 560 | 1,195 | 225 |
| Operating Cash Flow | $-438 | $-1,833 | $-979 | $-1,362 | $-1,186 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 2,094 | 2,094 | 2,094 | 2,094 |
| Financing Cash Flow | $N/A | $2,094 | $2,094 | $2,094 | $2,094 |
| Beginning Cash Position | 2,855 | 2,594 | 2,594 | 2,594 | 2,594 |
| End Cash Position | 2,417 | 2,855 | 3,709 | 3,326 | 3,502 |
| Net Cash Flow | $-438 | $261 | $1,115 | $732 | $908 |
| Free Cash Flow | |||||
| Operating Cash Flow | -438 | -1,833 | -979 | -1,362 | -1,186 |
| Free Cash Flow | -438 | -1,833 | -979 | -1,362 | -1,186 |